Acute chest pain (ACP) is a prevalent symptom in clinical practice, often indicative of potentially life-threatening conditions such as acute coronary syndrome (ACS) or pulmonary embolism. However, it may also stem from benign causes, necessitating a careful and systematic diagnostic approach.
ACP evaluation commences with a thorough history and physical examination. The aim is to identify high-risk features suggestive of ACS, including pain characteristics, associated symptoms, risk factors, and prior cardiac history. Concurrently, vital signs and physical findings can hint at alternative diagnoses, like aortic dissection or pericarditis.
Electrocardiogram (ECG) is the first-line diagnostic test, performed promptly to detect ST-segment elevation myocardial infarction (STEMI). Non-diagnostic ECGs do not exclude ACS and warrant further testing. Cardiac biomarkers, primarily high-sensitivity troponins, are invaluable in ACS diagnosis, with serial measurements recommended in the first 3 hours from symptom onset.
Chest X-ray, while typically normal in ACS, can reveal alternative diagnoses like pneumonia or pneumothorax. Computed tomography (CT) angiography is the imaging modality of choice for suspected pulmonary embolism or aortic dissection. Coronary CT angiography can also be used in low-risk patients to rule out coronary artery disease.
Risk stratification tools, such as the HEART score, guide further management. Low-risk patients might undergo stress testing or advanced imaging, while high-risk patients require hospitalization and invasive strategies.
ACP presents a diagnostic challenge, necessitating a systematic approach to distinguish serious from benign causes. A comprehensive history and physical examination, combined with judicious use of diagnostic tests and risk stratification tools, are pivotal in guiding management and improving patient outcomes. Continued research and technological advancements promise to refine this process further, enhancing our ability to accurately diagnose and treat this common clinical presentation.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation